Heart blocks treatment devices market seen reaching $4.74 billion by 2030

The Business Research Company says the heart blocks treatment devices market will rise from $3.36 billion in 2025 to $4.74 billion by 2030, driven by cardiovascular disease growth, an aging population, and wider use of remote monitoring and implantable cardiac devices. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Heart blocks treatment devices are becoming more important as heart disease rates rise and health systems need better tools to manage rhythm disorders. - The market’s projected jump to $4.74 billion by 2030 signals continued demand for implantable and monitoring-based cardiac care. - Growth in home-based care and digital heart health could reshape how patients with conduction disorders are treated.

What happened: - The Business Research Company released a market report on heart blocks treatment devices with a 2026–2035 outlook. - The report estimates the market will grow from $3.36 billion in 2025 to $3.59 billion in 2026. - The report projects the market will reach $4.74 billion by 2030, implying a 7.2% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The company also offered a free sample of the report and a full report download.

The details: - Heart blocks treatment devices are medical instruments used to manage interruptions in the heart’s electrical conduction system. - These devices help regulate heart rhythm and keep the atria and ventricles working in sync. - The report ties near-term growth to rising cardiovascular disease, better hospital cardiac care infrastructure, improved access to cardiac diagnostic services, and more reliable implantable devices. - The report points to remote patient monitoring, cardiac digital health investment, personalized rhythm management, home-based cardiac care, and implantable device innovation as future growth drivers. - Expected market trends include advanced pacemaker technologies, more implantable cardiac rhythm devices, remote cardiac monitoring systems, minimally invasive cardiac procedures, and longer-term rhythm management. - Cardiovascular diseases include coronary artery disease, heart failure and stroke. - A March 2024 GOV.UK update said more than 1,862,500 people in England, or about 3% of the population, were diagnosed with coronary heart disease in the financial year ending 2023. - A July 2024 House of Commons Library update said the UK had 12.7 million people aged 65 or older in 2022, or 19% of the population. - The same House of Commons Library data projects the UK 65-and-older population will rise to 22.1 million by 2072, equal to 27% of the population.

Between the lines: - The report suggests the market’s growth is being pulled by both disease burden and demographic change, not just device innovation. - North America’s lead points to established cardiac care spending, while Asia-Pacific’s faster growth hints at rising treatment access and healthcare investment. - The emphasis on remote monitoring and home care suggests vendors are competing on convenience, long-term management and connected care, not only on implant performance.

What’s next: - The market is expected to keep expanding as more patients need rhythm management and longer-term cardiac support. - More investment in digital health and minimally invasive procedures could speed adoption of next-generation devices. - The report indicates the next phase of competition will center on monitoring, personalization and integrated cardiac care platforms.

The bottom line: - Heart blocks treatment devices are moving from a niche cardiac category into a faster-growing global market shaped by aging populations, cardiovascular disease and connected care.